SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors rotate out of software and hyperscalers, fueled by concerns over AI-related capital expenditure and potential share dilution. The community is actively debating the stock's long-term potential versus its recent volatility, with many traders closely monitoring key support levels as they navigate a broader market shift away from the AI-driven breakout trade.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is seeing intense volatility as investors debate whether the sector is experiencing a temporary washout or the beginning of a larger bubble burst. The community is heavily focused on interpreting recent market reversals and potential macro headwinds, with many traders actively scaling into positions while navigating extreme price swings and concerns over decay.

EHang Holdings Ltd. engages in the provision of aerial vehicle technology platform company. It also provides unmanned aerial vehicle (UAV) systems and solutions: air mobility (including human transportation and logistics), smart city management, and aerial media solutions. The firm operates through the following geographical segments: P.R.C., West Asia, East Asia, South America, Europe, and Other. The company was founded by Huazhi Hu and Yifang Derrick Xiong in December 2014 and is headquartered in Guangzhou, China.

EHang Holdings Ltd - ADR

EHang Holdings

EHang continues to draw attention as investors monitor its progress toward scaling commercial operations and expanding global deployment, particularly in markets like Thailand and the Middle East. While community members remain divided over the company's timeline for recurring revenue and regulatory hurdles, ongoing interest is driven by the unveiling of new long-range models like the VT35 and the promise of a growing low-altitude economy.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending following a significant $2.6 billion agreement with Nebius Group to provide fuel cell capacity for AI data centers, which investors view as further validation of the company's critical role in solving the AI infrastructure power bottleneck. The community is actively discussing the stock's parabolic growth, debating its valuation, and drawing comparisons between Bloom's commercial success and the speculative potential of smaller clean energy plays like FuelCell Energy and Hyliion.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors brace for earnings results that follow a period of volatility driven by litigation concerns and broader biotech sector pressure. The community remains focused on the commercial growth of Recorlev, the upcoming Phase 3 advancement of the XP-8121 pipeline, and the potential for long-term valuation rerating as the company moves toward sustained profitability.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is under intense scrutiny as shareholders debate whether the stock is a deep-value opportunity ahead of earnings or a permanent laggard amid shifting consumer spending habits. While some investors are aggressively accumulating shares to capitalize on oversold conditions and potential institutional accumulation, others remain deeply skeptical due to thin margins, competitive pressure, and a persistent downtrend that has left the community divided on the stock's long-term viability.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup is attracting attention as a potential defensive value play following recent earnings, with investors closely watching the company's efforts to manage debt and offset rising costs through productivity and pricing. The community is actively discussing the stock's high dividend yield and potential for long-term turnaround as it navigates index rebalancing and sector-wide headwinds.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure is experiencing intense community focus as traders speculate that a recent job posting for a data center manager in Moses Lake points to an imminent hyperscaler lease announcement. While the stock has faced downward pressure following a large convertible notes offering, investors are actively debating the timing of potential contracts and highlighting the company's significant power capacity and strategic infrastructure positioning.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is facing intense community debate regarding its progress toward piloted flight compared to industry peers, with retail investors expressing concern over recent institutional selling and the company's timeline for commercial launch. Despite the skepticism surrounding delayed milestones, some bulls maintain a positive outlook by pointing to the company's strategic infrastructure developments and potential for growth heading into major upcoming global events.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF is trending as investors react to the news of Trulieve's upcoming NYSE uplisting, which has sparked widespread speculation about a sector-wide re-rating and improved institutional access. The community is actively debating the potential for a broader rally, with many focusing on this development as a key catalyst for the industry ahead of upcoming DEA rescheduling hearings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive...

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected...

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at...

CMPS Stock Is Breaking Out Again — Retail Traders Think A Major FDA Catalyst Is Brewing

Equity

Compass Pathways saw a pre-market boost on psychedelic therapy momentum, while retail flagged key FDA changes.

Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the...

Transcript: Compass Pathways Q1 2026 Earnings Conference Call

Compass Pathways Reports Strong Q1 Results, Shares Surge

COMPASS Pathways Plc (NASDAQ:CMPS) reported first-quarter earnings on Wednesday before the market open. Here's a rundown of the report.read more...

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial...

Jefferies Financial Group Upgrades Compass Pathways (NASDAQ:CMPS) to Strong-Buy

Jefferies Financial Group upgraded Compass Pathways to a "strong-buy" rating in a report on Tuesday...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards...

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

CMPSCOMPASS Pathways

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CMPS News